The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.
FDA's Division of Drug Information has posted new Drug Safety Podcasts for Healthcare Professionals. Click on the following links to read transcripts and listen to podcasts.
- FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C
You can download other Drug Safety Podcasts at: FDA Drug Safety Podcasts or subscribe to the Drug Safety Podcasts channel in iTunes at: Drug Safety Podcasts.
No hay comentarios:
Publicar un comentario